Skip to main content
. 2016 Feb 10;2(4):281–293. doi: 10.1021/acsinfecdis.5b00143

Figure 3.

Figure 3

MMV Malaria Box compounds are identified as potent malaria exoerythrocytic-stage inhibitors: 36 exoerythrocytic-stage active MMV Malaria Box hits with a Pb-Luc IC50 of less than 10 μM are shown with their respective IC50 values. Hits were also selected to demonstrate a HepG2 IC50 and a Luc IC50 of more than 10 μM. A line at 1 μM highlights that almost half of the exoerythrocytic-stage active hits display nanomolar potency. Error bars represent the 95% confidence interval.